Fatty liver disease – Page 3 – Blue Heron Health News

How does bariatric surgery affect fatty liver disease, supported by studies showing significant histological improvement, and how do surgical outcomes compare with lifestyle interventions alone?

hotsiagoodman

September 19, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

How does smoking influence fatty liver disease progression, supported by oxidative stress data, and how do quitters compare with current smokers in long-term outcomes?

hotsiagoodman

September 18, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

What role does vitamin D deficiency play in fatty liver disease, supported by studies linking low vitamin D to higher prevalence, and how does supplementation compare with lifestyle interventions?

hotsiagoodman

September 18, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

How does hypertension contribute to fatty liver prevalence, supported by metabolic syndrome data, and how do antihypertensive medications compare in worsening or improving outcomes?

hotsiagoodman

September 18, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

What is the impact of high cholesterol and triglyceride levels on fatty liver disease, supported by lipid metabolism studies, and how do statins compare with lifestyle modifications in improving liver health?

hotsiagoodman

September 17, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

How does polycystic ovary syndrome (PCOS) influence fatty liver prevalence, with up to 50% comorbidity, and how do insulin-sensitizing drugs compare with weight loss in outcomes?

hotsiagoodman

September 17, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

What role does gut microbiota play in fatty liver development, supported by evidence of dysbiosis in patients, and how do probiotic interventions compare with standard care?

hotsiagoodman

September 17, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

What is the relationship between fatty liver disease and cardiovascular risk, supported by evidence that NAFLD patients have higher heart disease mortality, and how does early detection compare with traditional risk screening?

hotsiagoodman

September 16, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

How does genetic predisposition contribute to fatty liver disease, with PNPLA3 variants linked to higher risk, and how do genetic factors compare with lifestyle factors in prevalence?

hotsiagoodman

September 16, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

What role does the Mediterranean diet play in improving fatty liver disease, supported by studies showing improved liver enzymes, and how does it compare with low-fat diets in long-term outcomes?

hotsiagoodman

September 16, 2025

The Non Alcoholic Fatty Liver Strategy™ By Julissa Clay the program discussed in the eBook, Non Alcoholic […]

Blue Heron Health News

Category: Fatty liver disease

How does bariatric surgery affect fatty liver disease, supported by studies showing significant histological improvement, and how do surgical outcomes compare with lifestyle interventions alone?

How does smoking influence fatty liver disease progression, supported by oxidative stress data, and how do quitters compare with current smokers in long-term outcomes?

What role does vitamin D deficiency play in fatty liver disease, supported by studies linking low vitamin D to higher prevalence, and how does supplementation compare with lifestyle interventions?

How does hypertension contribute to fatty liver prevalence, supported by metabolic syndrome data, and how do antihypertensive medications compare in worsening or improving outcomes?

What is the impact of high cholesterol and triglyceride levels on fatty liver disease, supported by lipid metabolism studies, and how do statins compare with lifestyle modifications in improving liver health?

How does polycystic ovary syndrome (PCOS) influence fatty liver prevalence, with up to 50% comorbidity, and how do insulin-sensitizing drugs compare with weight loss in outcomes?

What role does gut microbiota play in fatty liver development, supported by evidence of dysbiosis in patients, and how do probiotic interventions compare with standard care?

What is the relationship between fatty liver disease and cardiovascular risk, supported by evidence that NAFLD patients have higher heart disease mortality, and how does early detection compare with traditional risk screening?

How does genetic predisposition contribute to fatty liver disease, with PNPLA3 variants linked to higher risk, and how do genetic factors compare with lifestyle factors in prevalence?

What role does the Mediterranean diet play in improving fatty liver disease, supported by studies showing improved liver enzymes, and how does it compare with low-fat diets in long-term outcomes?

Health eBook